207TiP A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/ 5 -fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers

Autor: Bhargava, P.G., Ramaswamy, A., Dubashi, B., Kapoor, A., Srinivas, S., Shetty, O., Kaushal, R., Shah, A., Noronha, V., Joshi, A.P., Menon, N.S., Nashikkar, C., Gupta, A., Mishra, B.K., Sisodia, N., Pal, V., Kayal, S., Prabhash, K., Ostwal, V.S.
Zdroj: In Annals of Oncology November 2023 34 Supplement 4:S1554-S1555
Databáze: ScienceDirect